Literature DB >> 20094008

Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography.

Akitaka Tsujikawa1, Yumiko Ojima, Kenji Yamashiro, Sotaro Ooto, Hiroshi Tamura, Satoko Nakagawa, Nagahisa Yoshimura.   

Abstract

PURPOSE: The purpose of this study was to examine indocyanine green angiography of eyes with central serous chorioretinopathy (CSC).
METHODS: We retrospectively studied the medical records of 39 patients (41 eyes) with active CSC who were <50 years of age. All patients had undergone fluorescein angiography and indocyanine green angiography using a confocal laser scanning system.
RESULTS: On indocyanine green angiography, most patients showed choroidal abnormalities, such as filling delay, venous dilation, subretinal leakage, or focal areas of hyperfluorescence, that were attributed to choroidal vascular hyperpermeability. In addition, punctate hyperfluorescent spots were seen in 38 of 41 eyes (93%) with active CSC and in 29 of 37 fellow eyes (78%); these spots were seen in the macular area and outside the vascular arcade or in peripapillary locations, and they often appeared as clusters of distinct spots. A cluster of punctate hyperfluorescent spots was seen on midphase indocyanine green angiography, and focal areas of hyperfluorescence often appeared to expand with time from these punctate hyperfluorescent spots.
CONCLUSION: Focal areas of hyperpermeability in CSC may be derived from the leakage of tiny punctate spots in the inner choroid. Hyperpermeability of these lesions may be involved in the development of serous retinal detachment associated with CSC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20094008     DOI: 10.1097/IAE.0b013e3181c72068

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  27 in total

1.  Response of central serous chorioretinopathy evaluated by multimodal retinal imaging.

Authors:  R Sacconi; G Baldin; A Carnevali; L Querques; A Rabiolo; G Marchini; F Bandello; G Querques
Journal:  Eye (Lond)       Date:  2018-01-05       Impact factor: 3.775

2.  [Spectral domain OCT in central serous chorioretinopathy: description of retinal changes].

Authors:  V Valet; C P Lohmann; M Maier
Journal:  Ophthalmologe       Date:  2012-09       Impact factor: 1.059

3.  Clinical characteristics of pachydrusen in central serous chorioretinopathy.

Authors:  Hidetaka Matsumoto; Ryo Mukai; Masahiro Morimoto; Shunsuke Tokui; Shoji Kishi; Hideo Akiyama
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-03-09       Impact factor: 3.117

4.  A novel mutation of sgk-1 gene in central serous chorioretinopathy.

Authors:  Mahmut Akyol; Muhammet Kazım Erol; Ozdemir Ozdemir; Deniz Turgut Coban; Ahmet Burak Bilgin; Esin Sogutlu Sari; Elif Betul Turkoglu
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

5.  Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy.

Authors:  A Rabiolo; I Zucchiatti; A Marchese; G Baldin; R Sacconi; D Montorio; M V Cicinelli; L Querques; F Bandello; G Querques
Journal:  Eye (Lond)       Date:  2017-12-21       Impact factor: 3.775

6.  Intravitreal aflibercept for ranibizumab-resistant exudative age-related macular degeneration with choroidal vascular hyperpermeability.

Authors:  Yoko Nomura; Yasuo Yanagi
Journal:  Jpn J Ophthalmol       Date:  2015-05-16       Impact factor: 2.447

7.  Focal choroidal excavation: a preliminary interpretation based on clinic and review.

Authors:  Guang-Hui Liu; Bing Lin; Xin-Quan Sun; Zi-Fang He; Ji-Rong Li; Rong Zhou; Xiao-Ling Liu
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

8.  Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients.

Authors:  G A Kim; T H Rim; S C Lee; S H Byeon; H J Koh; S S Kim; C S Lee
Journal:  Eye (Lond)       Date:  2015-05-08       Impact factor: 3.775

9.  Polypoidal choroidal vasculopathy in patients aged less than 50 years: characteristics and 6-month treatment outcome.

Authors:  Young Suk Chang; Jae Hui Kim; Jong Woo Kim; Tae Gon Lee; Chul Gu Kim; Sung Won Cho
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-19       Impact factor: 3.117

10.  Subfoveal choroidal thickness as a predictor of central serous chorioretinopathy.

Authors:  V Ambiya; R Yogi; A Li; S Shah; C Sarvaiya; P Mehta; C Meyerele; L Wu; R Singh; A Banker; J Chhablani
Journal:  Eye (Lond)       Date:  2016-09-30       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.